Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

New York · 2025 Regular Session · Bill

S 7668: Prohibits the sale of xylazine above a certain weight

In committee Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

S 7668 is a bill introduced in the New York Senate on April 28, 2025. According to its official title, it concerns: Prohibits the sale of xylazine above a certain weight. Primary sponsor: Nathalia Fernández (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO CONSUMER PROTECTION.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

Prohibits the knowing sale of xylazine above a certain weight to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Sponsors

Sponsors by party (alphabetical): Democratic 1

NameRolePartyChamberDistrict
Nathalia FernándezPrimary sponsorDemocraticSenate34

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. REFERRED TO CONSUMER PROTECTION
  2. COMMITTED TO RULES
  3. ADVANCED TO THIRD READING
  4. AMENDED 7668A
  5. 2ND REPORT CAL.
  6. 1ST REPORT CAL.1135
  7. REFERRED TO CONSUMER PROTECTION

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source